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Infection by the Human Papilloma Virus (HPV) is one of 
the most frequent sexually transmitted diseases all over the 
world. The relationship between oral and genital HPV remains 
uncertain, as it is with its role on oral carcinogenesis. The goal 
of the present investigation was to check for the presence of 
HPV DNA in the oral and genital mucosas of women with 
HPV genital infection, using the polymerase chain reaction 
(PCR). Study method: Cross-sectional cohort. Materials and 
Methods: this is a pilot and prospective study involving 30 
women, aged between 14 and 51 years, with HPV genital 
infection, confirmed by histopathology. All the patients were 
submitted to the exam and sample collection by swabbing 
the oral and genital mucosas in order to test for HPV DNA 
through the PCR technique. Results: none of the oral cavity 
samples were positive for HPV, while in the genital tract, HPV 
was detected in 17 (57%) of the 30 patients, especially HPVs 
6b and 16. Conclusion: Results show a higher percentage 
of genital HPV in comparison to the oral cavity, and suggest 
that genital HPV does not seem to be a predisposing factor 
for the oral infection in the same patient.
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INTRODUCTION
The human papillomavirus (HPV) belongs to a 
heterogeneous1 group of DNA viruses that infect the skin 
and mucosae in various sites of the human body.2
The transmission mode of this virus to the oral 
mucosa is not clearly known. It has been suggested that 
transmission may occur during vaginal birth, self-inocu-
lation, or oral sex.3-5
It appears that saliva has a protective role against 
HPV infection due to the presence of antimicrobial agents 
such as lysozymes, lactoferrin, IgA and cytokines.6,7
The most frequently affected sited in the mouth 
are the lips, palate, tongue, gingiva, uvula, tonsils, and 
the floor of the mouth. Saliva accumulates on the floor 
of the mouth; cancerous agents dissolved in saliva, such 
as tobacco and alcohol, provide ample opportunity for 
harmful viral activity.8,9
HPV infection has classically been divided into three 
separate manifestations: clinical, subclinical and latent for-
ms. Clinical infection is easily detected with the naked eye, 
in the form of a wart. The subclinical form occurs more 
frequently on the cervix (80% of cases) and is diagnosed 
by colposcopy after applying 5% acetic acid. The latent 
form is diagnosed only by molecular biological tests.10,11
Biopsies are used to study the pathology of a spe-
cimen and to grade the disease. Molecular biological tests 
are required for diagnosing HPV and defining its type.12
Hybridization tests of tissue samples and smears 
are currently the methods of choice for detecting the HPV 
DNA. These methods include the dot blot, the Southern 
blot, in situ hybridization, and the polymerase chain 
reaction (PCR); the latter is the most sensitive of these 
tests.13,14
The PCR increases - by many million times - minute 
amounts of target DNA sequences. Initiating systems (pri-
mers) are used, the most common being the MY09-MY11 
and the GP5-GP6 primer systems.15-17
HPV types vary according to their tissue tropism, 
their associations with different lesions and their oncoge-
nic potential. These types may be characterized as low 
risk HPVs for developing malignancies (types 6, 11, 41, 
43, 44) and high risk HPVs for developing malignancies 
(16, 18, 31, 33, 35, 39, 45, 46, 51, 52). Types 6 and 11 are 
the two main types involved in most of the genital warts 
(condylomas); types 16 and 18 are found mainly in cer-
vical cancer.12,16,17
Over 100 HPV types have been found to date.18-
20 Of these, 25 types (HPV-1, 2, 3, 4, 6, 7, 10, 11, 13, 16, 
18, 31, 32, 33, 35, 40, 45, 52, 55, 57,58, 59, 69, 72 and 73) 
have been associated with benign oral lesions (squamous 
cell papilloma), condylomata acuminata, common warts, 
focal epithelial hyperplasia, and malignancies such as the 
squamous cell carcinoma.21
Many researchers have studied oral and genital HPV 
to discover whether genital infection by this virus could 
lead to infection elsewhere, such as in the mouth.22-26
Van Doornum et al.22 (1992) applied the PCR to 
study oral and genital HPV in 65 males and 111 females. 
Examination of the mouth consisted of unaided visual 
inspection and scrapes for further study. Genital HPV 
was found in 21 (32%) of 65 males and 25 (23%) of 111 
females; none of these patients had oral HPV. There were 
no reports of oral sex.
Badarrocco et al.23 (1998) applied the PCR and found 
oral HPV in five of ten women diagnosed with genital HPV. 
Unaided visual inspection of the mouth and colposcopy 
was don in all patients; oral scrapes were taken. There 
were no reports of oral sex.
Camadas et al.24 (2004) applied the PCR to study 
genital and oral HPV in 188 females. Unaided visual ins-
pection was done of the mouth and scrapes were made. 
The positivity rate in the mouth was 15 (7.9%). There were 
no reports of oral sex.
Giraldo et al.25 (2006) found positive HPV PCR tes-
ting in 29 (20.7%) of 140 females with or with no genital 
lesions. Scrapes were taken from the oral mucosa in which 
unaided visual inspection had been carried out. These 
authors also highlighted that genital HPV was present in 
26 (89%) of 29 females with oral HPV, as detected by the 
PCR. Oral sex was practiced by 16 (55.2%) of 29 women 
with positive oral HPV, and by 59 (23.2%) of 111 women 
that tested negative for oral HPV.
Xavier et al.26 (2007) applied the PCR to test 10 
males with PCR-confirmed genital HPV for oral HPV. Unai-
ded visual inspection was done of the mouth and scrapes 
were made. None of these patients had the HPV in the 
oral mucosa; there were no reports of oral sex.
Further investigation is required on this theme, 
considering the conflicting results described in the lite-
rature about the presence and relation of oral HPV with 
genital HPV.
The purpose of this study was to verify the presence 
of HPV DNA in the oral and genital mucosa of patients with 
genital HPV infection by applying the PCR technique.
MATERIAL AND METHOD
A retrospective study was done from May 2005 to 
November 2006. The Research Ethics Committee of the 
UFAL approved the study (protocol number 005564/02-50). 
All patients were informed about the purpose of the study 
and the required procedures if participating. All of them 
read and signed a free informed consent form.
The inclusion criteria were sexually active female 
subjects aged from 14 to 51 years that presented clinical 
or subclinical genital HPV. Exclusion criteria were patients 
with immunological conditions, such as HIV infection, 
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immunosuppressed patients, and users of immunosup-
pressant drugs.
Thirty patients with genital warts (clinical and/or 
subclinical) suggesting HPV infection were recruited. All 
subjects underwent a gynecological exam, colposcopy 
(with 5% acetic acid), and biopsies of warts for diagnosis. 
Scrapes for cytology using sterilized brushes (colpocyto-
logy kits, Libbs®) were taken from genital lesion sites 
(external genital, vagina and cervix) during colposcopy.
On the same day, unaided visual inspection was 
made of the oral cavity, using artificial light (photophore) 
in an attempt to identify any clinical lesion that might 
suggest HPV infection. Samples were taken from sites 
where the HPV was likely to be found by scraping the oral 
mucosa with sterilized brushes (the soft palate, the uvula, 
the tonsils, dorsum of tongue, the sublingual area, and the 
jugal mucosa. Examination of the mouth did not include 
use of a colposcopy or application of acetic acid.
The scrapes were placed in separate vials containing 
a buffer solution (tris-HCL 10mM, pH 8, EDTA 1mM ) and 
identified as either genital or oral; the vials were sent to 
the Molecular Biology Laboratory of the Universidade 
Federal de Alagoas (UFAL) and stored at -20ºC for testing 
with the PCR technique.
Extraction of genomic DNA was done using the 
GFX kit (Asmersham Bioscience) method; the DNA con-
centration in each sample was estimated using a spectro-
photometer (Genova). The MY09/MY11 primer systems 
were used for viral DNA amplification; viral types were 
identified according to their electrophoretic patterns.
Subjects also answered a standard questionnaire on 
epidemiological issues, such as the beginning of sexual 
life, the number of partners, oral sex, use of alcohol and 
smoking.
RESULTS
The epidemiological survey revealed that 22 of 30 
patients (73%) engaged in oral sex, and 16 patients (53%) 
engaged in anal sex; nine patients (30%) were smokers 
and none consumed alcoholic beverages; Table 1 presents 
these results.
The results of colposcopy showed subclinical lesions 
in 19 patients (63%) of, subclinical lesions in eight patients 
(27%), and clinical lesions in three patients (10%), located 
mostly on the cervix. All 30 samples of genital lesions were 
positive for HPV. Table 1 shows these results.
The results of PCR testing of genital samples were 
positive in 17 cases (57%) of the 30 patients; 13 cases had 
negative samples. The most frequent HPV type was the 
6b type, found in seven (41%) of the 17 positive samples, 
followed by type 16 in four samples (23%). Types HPV66, 
HPV52, and HPV31 were found in one sample each (6%). 
The type could not be determined in three samples (18%). 
Table 1 shows these results.
Unaided visual inspection of the mouth of 30 sub-
jects revealed no clinical lesions suggesting HPV.
PCR test results in 30 samples of oral scrapings 
were HPV negative.
DISCUSSION
In this study 19 (63%) of 30 patients had only sub-
clinical genital HPV infection, mostly in the cervix, which 
was confirmed by colposcopy. This is similar to other 
published studies, showing that this is the most frequent 
HPV infection.10,11
Histology is an important method for diagnosing 
HPV infection; all of the genital samples had histological 
changes that suggested this diagnosis. This may be con-
sidered as a routine first exam for the diagnosis of HPV 
infection. However, since histology is unable to identify 
the HPV, molecular biology techniques are needed for 
confirming HPV infection;12 this is done mostly using 
PCR techniques, which is more sensitive for detecting the 
HPV.13,14
The PCR technique was the method we chose 
to identify oral and genital HPV in this study; we used 
the MY09-MY11 primer systems,16-18 which is the most 
sensitive13,14 and preferred method for detecting HPV DNA 
in tissue smears and samples.14
The most frequent HPV types found in the genital 
area of 17 patients that were PCR-positive for HPV were 
the types 6b (41%) and 16 (23%). The former is a low-risk 
type and is frequently found in genital condylomas; the 
latter is found mainly in cervical cancer.17
The number of smokers in the 30-patient sample 
was nine (30%); none of them consumed alcoholic beve-
rages. These variables did not affect the results, although 
they are factors that favor HPV infection in the mouth.8,9
The samples of the mouth were PCR-negative in 
all 30 patients of this study. In other studyes22-26 that used 
the same technique, the positivity rate ranged from 0 to 
50%. We concluded that the presence of genital HPV 
infection does not appear to be a predisposing factor for 
oral HPV infection. This result is important for patients 
with genital HPV infection who become worried about 
possible transmission of the disease to their partner(s) and 
to other bodily sites.
Low immunological defense is probably the most 
important factor for HPV infection in other sites of the 
body. The mouth contains IgA and proteolytic enzymes 
that protect against HPV infection.6,7
HPV transmission to the mouth is not yet clearly 
understood.3-5 The rate of oral sex was high in our sample; 
however, the results of oral HPV infection were negative in 
73% of cases. Compared with other studies,22-26 we found 
that few patients were aware of this transmission mode to 
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Table 1. Individual results of the 30 subjects in this study
N Age
Genital 
lesion 
Site HPV type Histological diagnosis 
Beginning 
of sexual 
activity
Number 
of sexual 
partners 
Oral 
sex 
Anal 
sex 
Smoking
1 32 subclinical cervix 16 SIL high grade 17 3 no no no
2 30 subclinical Cervix 16 Alt. suggest. HPV 17  4 yes yes yes
3 36
Clinical / 
subclinical
Cervix / vulva 6b SIL low grade 17 2 yes yes no
4 19 subclinical cervix - Alt. suggest. HPV 13 1 yes no no
5 24 subclinical cervix In. SIL low grade 22 1 no no no
6 29 subclinical Cervix ,vagina - Alt. suggest. HPV 19 4 yes yes no
 7 39 subclinical cervix - SIL low grade 17 5 yes no no
 8 21  Clinical
Cervix, vulva , 
vagina
 6b condyloma 20 1 no no  no
9  15
 Clinical / 
subclinical
Cervix / vulva - Alt. suggest. HPV 14 1 yes no no
10 21 subclinical cervix - SIL low grade 18 5 yes yes no
11 51 subclinical cervix 66 SIL low grade 22 3 yes yes no
12 42 subclinical cervix - Alt. suggest. HPV 15 2 yes yes yes
13 21
 Clinical / 
subclinical
Cervix, vulva, 
vagina
6b SIL low grade 16 2 yes yes yes
14 19 subclinical Vulva, vagina - Alt. suggest. HPV 15 2 yes yes yes
15 17
Clinical / 
subclinical
Cervix, vulva  6b condyloma 12 2 yes no no
16 36 subclinical cervix - Alt. suggest. HPV 18 2 yes no yes
17 25 subclinical cervix 16 e MM8 SIL low grade 13 3 yes no no
18 32 subclinical vagina   - Alt. suggest. HPV 15  6 yes yes no
19 45 Clinical Vulva, anus 6b condyloma 19 4 yes yes yes
20 32 subclinical cervix In. SIL low grade 17 1  no no yes
21 19 subclinical Cervix, vagina - SIL low grade 15 3 yes yes no
 22 14
Clinical / 
subclinical
Cervix,vulva, 
vagina
16 SIL high grade 14 1 yes yes no
23 32 subclinical   cervix 31 SIL low grade 16 2 yes yes no
24 21
Clinical / 
subclinical
Cervix, vulva 6b Alt. suggest. HPV 15 2 yes yes no
25 24 subclinical cervix 6b SIL low grade 15 1 yes yes no
26 16
Clinical / 
subclinical
Cervix, vulva / 
vagina
- Alt. suggest. HPV 13 4 yes yes yes
27 32 subclinical Cervix 52 SIL low grade 15 1 no no no
28 36
Clinical / 
subclinical
Cervix, vulva / 
vagina
- Alt. suggest. HPV 28 2 no no no
29 34 Clinical vagina In. Alt. suggest. HPV 18 1 no no no
30 32 subclinical cervix - SIL high grade 22 2 no no no
HPV=human papilloma virus; In=Indeterminate; SIL=Squamous intraepithelial lesions
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the mouth; it was thus impossible to  conclude whether 
patients with genital lesions that engaged in oral sex were 
more predisposed to have oral HPV infection.
Further studies are needed on the relation between 
oral and genital HPV infection to explain its action on the 
oral mucosa.
CONCLUSION
In this study, the percentage of HPV infection  was 
higher in the genital area (57%) compared to the oral muco-
sa (0%); this suggests that genital HPV is not a predisposing 
factor for oral HPV infection in the same patient.
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